Sana Biotechnology (SANA) Accumulated Depreciation (2020 - 2026)

Sana Biotechnology's Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $57.1 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation changed 0.33% year-over-year to $57.1 million; the TTM figure through Mar 2026 stood at $57.1 million (changed 0.33% YoY), while the FY2025 annual figure was $54.8 million, up 1.09% from the prior year.
• Accumulated Depreciation came in at $57.1 million for Q1 2026 at Sana Biotechnology, up from $54.8 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $57.3 million in Q1 2025 to a low of $22.4 million in Q1 2022.
• A 5-year average of $44.7 million and a median of $47.3 million in 2023 frame the typical range for Accumulated Depreciation.
• Across the five-year window, Accumulated Depreciation soared 124.24% in 2022 and fell 0.33% in 2026, its largest moves.
• Sana Biotechnology's Accumulated Depreciation stood at $34.0 million in 2022, then climbed by 22.94% to $41.8 million in 2023, then grew by 29.67% to $54.2 million in 2024, then advanced by 1.09% to $54.8 million in 2025, then rose by 4.37% to $57.1 million in 2026.
• According to Business Quant data, Accumulated Depreciation over the past three periods registered $57.1 million, $54.8 million, and $53.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison